Impact of high-risk features for stage II adenocarcinoma of the appendix.
Explore this paper's citation graph
Summary
High-risk stage II AA patients had significantly worse 5-year OS compared to low-risk patients and AC did not improve survival regardless of high-risk features in stage III appendiceal adenocarcinoma in this retrospective study.
- Type
- article
- Published
- 2020-02-01
- Cited by
- 5
- References
- 32
- OpenAlex
- https://openalex.org/W3005468689
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:212886442
Keywords
Medicine, Stage (stratigraphy), Internal medicine, Lymphovascular invasion, Adenocarcinoma
References
- Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma.
- Adjuvant chemotherapy use and outcomes of patients with high‐risk versus low‐risk stage II colon cancer
- The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: analysis of the National Cancer Data Base (NCDB)
- Do High-risk Features Support the Use of Adjuvant Chemotherapy in Stage II Colon Cancer? A Turkish Oncology Group Study
- Adjuvant chemotherapy of stage III colon cancer.
- Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
- The Natural History of Surgically Treated Primary Adenocarcinoma of the Appendix
- Primary malignant neoplasms of the appendix
- Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade
- High‐risk stage II colon cancer after curative resection
- Challenges in the management of stage II colon cancer
- Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
- American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
- Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.
- Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
- Management of Appendix Cancer
- Adjuvant chemotherapy is not associated with improved survival for all high‐risk factors in stage II colon cancer
- A year from diagnosis.
- Primary adenocarcinoma of the appendix: Experience at La Paz University Hospital of Madrid (1967–2014)
- High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer
Cited by
- Cortical Morphometry and Its Relationship with Cognitive Functions in Children after non-CNS Cancer
- Chemotherapy in the treatment of different histological types of appendiceal cancers: a SEER based study
- Mutational signatures in appendiceal adenocarcinomas: potential for future personalization in hyperthermic intraperitoneal chemotherapy?
- Comprehensive Analysis of CD44 in Colorectal Cancer: Molecular Mechanisms, Isoform Interactions, and Targeted Treatments to Address Tumorigenesis and Chemoresistance
- Is Adjuvant Chemotherapy Necessary for Stage IIB/IIC Appendiceal Adenocarcinoma?
Related papers
- Clinicopathologic analysis of 22 cases of cervical adenocarcinoma
- Histological and prognostic data on surgically resected early-stage lung adenocarcinoma
- Analysis of Clinical Parameters Affecting Recurrence of Meningiomas
- Analysis of recurrence in meningiomas
- Gender and Age Differences in Risk Factors of Lymph Node Metastasis in Patients With Early Gastric Cancer and Analysis Prognosis of Early Gastric Cancer
- Retrospective survival analysis of stage II–III rectal cancer: tumour regression grade, grading and lymphovascular invasion are the only predictors
- Can Lymphovascular Invasion be Predicted by Preoperative Contrast-Enhanced CT in Esophageal Squamous Cell Carcinoma?
- Clinical characteristics and prognostic analysis of lung adenocarcinoma
- The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection.